Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-7,000
Closed -$1.07M 95
2015
Q2
$1.07M Sell
7,000
-11,000
-61% -$1.76M 0.1% 79
2015
Q1
$2.88M Sell
18,000
-2,500
-12% -$394K 0.25% 49
2014
Q4
$3.27M Sell
20,500
-27,000
-57% -$4.21M 0.29% 44
2014
Q3
$6.67M Hold
47,500
0.59% 18
2014
Q2
$5.62M Buy
47,500
+13,500
+40% +$1.56M 0.47% 23
2014
Q1
$4.19M Buy
+34,000
New +$4.12M 0.34% 33

Other funds holding AMGN

Dow Chemical Company's AMGN Position: Q3 2015 in Review

Dow Chemical Company sold out of Amgen (AMGN) in Q3 2015, closing a stake of 7,000 shares — an estimated $1.07M sold.

Dow Chemical Company first reported a position in AMGN in Q1 2014 and held it in 6 quarters. The position peaked at $6.67M in Q3 2014. 1,380 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

  • Dow Chemical Company reported no remaining Amgen position as of Q3 2015 after selling out during the quarter.
  • Dow Chemical Company sold 7,000 Amgen shares in Q3 2015, an estimated $1.07M.
  • Dow Chemical Company first reported a position in Amgen in Q1 2014 and held it in 6 quarters.
  • Dow Chemical Company's Amgen position peaked at $6.67M in Q3 2014.
  • 1,380 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on Dow Chemical Company's 13F filing for Q3 2015, filed 13 Nov 2015.